BetterLife Pharma Inc. (BETRF): Cash & Equivalents

Annual figures by period end, from SEC filings.

Not updated since 2019-01-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

74.8K CAD
As of 2019-01-31
n/m
5-year compound annual growth
79.3K CAD2012-01-31: 2.1K CAD2013-01-31: 475 CAD2014-01-31: 1.0K CAD2015-01-31: 1.1K CAD2018-01-31: 79.3K CAD2019-01-31: 74.8K CAD74.8K CAD
2012-01-31 Cash & Equivalents (CAD) 2019-01-31
Period endedCash & EquivalentsChange YoYSource filing
2019-01-3174.8K CAD-5.7%2019-05-03, Balance as of period end
2018-01-3179.3K CADn/a2019-05-03, Balance as of period end
No annual figure between 2015-01-31 and 2018-01-31.
2015-01-311.1K CAD+2.2%2015-06-17, Balance as of period end
2014-01-311.0K CAD+119.8%2015-06-17, Balance as of period end
2013-01-31475 CAD-77.0%2014-05-16, Balance as of period end
2012-01-312.1K CADn/a2014-05-16, Balance as of period end